Search results for "Invasive"

showing 10 items of 1141 documents

Cost-effectiveness of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma

2009

Oncologymedicine.medical_specialtyCost effectivenessComputed tomographyInternal medicineBiopsymedicinebiopsynon-invasive diagnosiAASLDHepatologymedicine.diagnostic_testRecallbusiness.industryNon invasiveGastroenterologycomputed tomographymedicine.diseaseAmerican Association for the Study of the Liver Diseasegadolinium-magnetic resonance imagingsmall hepatocellular carcinomaCost-effectiveneHepatocellular carcinomaRadiologybusinesscontrast-enhanced ultrasoundContrast-enhanced ultrasoundDigestive and Liver Disease
researchProduct

Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients

2011

Endoscopic local procedures are increasingly applied in patients with superficial esophageal cancer as an alternative to radical oncologic resection. The objective of this article is to determine the risk of nodal metastases in submucosal (sm) esophageal cancer, comparing the two predominating histologic tumor types, squamous cell cancer (SCC) and adenocarcinoma (ADC).A query of PubMed, MEDLINE, Embase and Cochrane Library (1980-2009) using predetermined search terms revealed 675 abstracts, of which 485 full-text articles were reviewed. A total of 105 articles met the selection criteria. A review of article references and consultation with experts revealed additional articles for inclusion.…

Oncologymedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatmentMEDLINEAdenocarcinomaCochrane LibraryRisk AssessmentEsophagusRisk FactorsInternal medicineCarcinomaHumansMedicineNeoplasm InvasivenessLymph nodeNeoplasm StagingMucous MembraneHepatologybusiness.industryPatient SelectionGastroenterologyEsophageal cancermedicine.diseaseEsophagectomymedicine.anatomical_structureEsophagectomyLymphatic MetastasisCarcinoma Squamous CellLymph Node ExcisionAdenocarcinomaEsophagoscopyRadiologybusinessRisk assessmentExpert Review of Gastroenterology & Hepatology
researchProduct

Impact of molecular and histological subtype of breast cancer on 18FDG-PET/CT imaging: Knowledge gained from recent studies

2016

International audience; Over the past few years, several studies have focused attention on the impact of breast cancer (BC) histological subtype or BC phenotype, as defined by hormone receptors (HR) and HER2 status, on the results of FDG-PET/CT at staging, or during neoadjuvant chemotherapy (NAC). At staging, sclerotic bone metastases from invasive lobular carcinoma (ILC) demonstrated low or no FDG uptake in comparison to metastases from invasive ductal carcinoma (IDC). The CT component of PET/CT imaging should be carefully analyzed in the staging of ILC. In patients with triple negative or HER2-positive tumors, the proportion of extraskeletal metastases is high; this must be taken into acc…

Oncologymedicine.medical_specialtyPathologyStagingPET/CTmedicine.medical_treatmentBiophysicsEstrogen receptorER-positive breast cancerNeoadjuvant chemotherapy030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineBreast cancerBreast cancerTriple-negative breast cancerResponse assessmentInternal medicine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyMedicineRadiology Nuclear Medicine and imagingskin and connective tissue diseasesHER2-positive breast cancerTriple-negative breast cancerChemotherapyPET-CTPathological complete responseRadiological and Ultrasound Technologybusiness.industrymedicine.disease18fdg pet ctPrognosis3. Good healthHormone receptor030220 oncology & carcinogenesisInvasive lobular carcinoma(18)FDGbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Role of robotic surgery in ovarian malignancy

2017

As part of minimally invasive surgery, robotic-assisted approach is becoming increasingly popular in gynecologic oncology. It has been shown to be effective and feasible for staging and treating endometrial and cervical cancer, but its role in the context of primary and recurrent ovarian cancers is presently debated. Scanty data are available in the literature, and the level of evidence supporting its use in ovarian cancer is quite low. However, from a retrospective case-control series, robotic surgery seems to be safe and feasible for early-stage ovarian cancer. Its use in treating patients with advanced-stage or relapsed ovarian cancer is still highly controversial, suggesting the choice …

Oncologymedicine.medical_specialtyPopulationContext (language use)robotic surgery ovarian cancerGynecologic oncologygynecologic oncology03 medical and health sciencesGynecologic Surgical Procedures0302 clinical medicineRobotic Surgical ProceduresInternal medicinerobotic surgerymedicineHumansRobotic surgeryeducationOvarian malignancygynecologic oncology; minimally invasive surgery; ovarian cancer; robotic surgery; Obstetrics and Gynecologyminimally invasive surgeryNeoplasm StagingRetrospective StudiesOvarian NeoplasmsCervical cancereducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryGeneral surgeryObstetrics and GynecologyGeneral MedicineEvidence-based medicinemedicine.diseasegynecologic oncology; minimally invasive surgery; ovarian cancer; robotic surgery; Case-Control Studies; Female; Gynecologic Surgical Procedures; Humans; Neoplasm Recurrence Local; Neoplasm Staging; Ovarian Neoplasms; Retrospective Studies; Robotic Surgical Procedures; Treatment OutcomeTreatment Outcomeovarian cancerSettore MED/40 - GINECOLOGIA E OSTETRICIACase-Control Studies030220 oncology & carcinogenesisFemaleNeoplasm Recurrence LocalbusinessOvarian cancer
researchProduct

A RANDOMISED STUDY EVALUATING MAINTENANCE SCHEDULE IN EARLY ADJUVANT CHEMOTHERAPY FOR INTERMEDIATE RISK NON-MUSCLE-INVASIVE BLADDER CANCER

2008

ABSTRACT Introduction and Objective: Adjuvant intravesical chemotherapy or BCG immunotherapy after transurethral resection (TUR) is a standard treatment for non–muscle-invasive transitional cell cancer of the bladder (NMI TCCB) at intermediate risk. Although the clinical value of early intravesical adjuvant chemotherapy is well established, the optimal schedule regimen and the role of maintenance is still debated. Methods: Between May 2002 and August 2003, 577 patients, undergoing TUR for NMI TCCB, were recruited. All patients underwent TUR and early (within 6 hours) intravesical chemotherapy with epirubicin at the dose of 80 mg diluted in 60 ml of saline solution. When histology was availa…

Oncologymedicine.medical_specialtyScheduleBladder cancerAdjuvant chemotherapybusiness.industryUrologymedicine.diseasebladder cancer EARLY ADJUVANT CHEMOTHERAPYInternal medicinemedicineNon muscle invasivebusinessIntermediate riskEuropean Urology Supplements
researchProduct

Non-invasive diagnosis of oral cancer: The role of electro-analytical methods and nanomaterials

2017

Abstract Oral cancer is a kind of head and neck cancer and is each cancerous tissue growth located in the oral cavity. Non-invasive early diagnosis of oral cancer is the most effective means to reduce death from this disease or increase the survival time. In this review, various types of electro-analytical methods for detection of oral cancer were discussed. The emphasis is placed on non-invasive detection of oral based on immune-, geno-, cyto-, apta-, and enzyme-biosensing strategies. In the first part of review, various electrochemical immunosensing methods for the detection of common biomarker in oral cancer and examines their potential as a new method were discussed. In the second part …

Oncologymedicine.medical_specialtybusiness.industry010401 analytical chemistryHead and neck cancerNon invasiveCancerNanotechnology02 engineering and technologyDisease021001 nanoscience & nanotechnologymedicine.diseaseOral cavity01 natural sciences0104 chemical sciencesAnalytical ChemistryBiomarker (cell)stomatognathic diseasesInternal medicinemedicineElectrochemical biosensor0210 nano-technologybusinessSpectroscopyBiomedicineTrAC Trends in Analytical Chemistry
researchProduct

Clinical Validation of 13-gene DNA Methylation Analysis from Oral Brushing: A Non Invasive Sampling Procedure for Early Detection of Oral Squamous Ce…

2019

In a recent study our research group described a non-invasive sampling procedure based on [...]

Oncologymedicine.medical_specialtyoral brushing;oral squamous cell carcinoma; quantitative DNA methylation analysisbusiness.industryEarly detectionSampling (statistics)oral brushingoral squamous cell carcinomaInternal medicineDNA methylationMedicinequantitative DNA methylation analysisBasal cellGene DNA Methylation Analysis Oral Brushing Non Invasive Sampling Early Detection Oral Squamous Cell CarcinomabusinessNon invasive samplingGeneThe XV National and III International Congress of the Italian Society of Oral Pathology and Medicine
researchProduct

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

2006

Item does not contain fulltext BACKGROUND: Loss of TP53 function through gene mutation is a critical event in the development and progression of many tumour types including colorectal cancer (CRC). In vitro studies have found considerable heterogeneity amongst different TP53 mutants in terms of their transactivating abilities. The aim of this work was to evaluate whether TP53 mutations classified as functionally inactive (< or=20% of wildtype transactivation ability) had different prognostic and predictive values in CRC compared with mutations that retained significant activity. MATERIALS AND METHODS: TP53 mutations within a large, international database of CRC (n = 3583) were classified ac…

Oncologyp53MaleNutrition and Diseasebinding domainsLymphovascular invasionColorectal cancerDNA Mutational AnalysisAetiology screening and detection [ONCOL 5]Gene mutationmedicine.disease_causeTransactivationVoeding en ZiekteAntineoplastic Combined Chemotherapy ProtocolsDeterminants in Health and Disease [EBP 1]transcriptional activityMutationHematologyExonsMiddle AgedSurvival RateOncologyAdenocarcinomaFemaleColorectal Neoplasmsmedicine.medical_specialtyAdenocarcinomachemotherapy colorectal cancer mutation prognosis TP53 transactivational abilityMolecular epidemiology [NCEBP 1]Breast cancerTranslational research [ONCOL 3]Interventional oncology [UMCN 1.5]Internal medicinemedicineHumansNeoplasm InvasivenessSurvival rateneoplasmsbreast-cancerVLAGAgedNeoplasm StagingHereditary cancer and cancer-related syndromes [ONCOL 1]business.industryInternational Agenciesmedicine.diseaseImmunologyMutationTumor Suppressor Protein p53businessFollow-Up Studies
researchProduct

High flow nasal therapy in perioperative medicine: from operating room to general ward

2018

Abstract Background High flow nasal therapy (HFNT) is a technique in which humidified and heated gas is delivered to the airways through the nose via small nasal prongs at flows that are higher than the rates generally applied during conventional oxygen therapy. The delivered high flow rates combine mixtures of air and oxygen and enable different inspired oxygen fractions ranging from 0.21 to 1. HFNT is increasingly used in critically ill adult patients, especially hypoxemic patients in different clinical settings. Main body Noninvasive ventilation delivers positive pressure (end-expiratory and inspiratory pressures or continuous positive airway pressure) via different external interfaces. …

Operating Roomsmedicine.medical_specialtymedicine.medical_treatmentPositive pressureReviewAcute respiratory failurePerioperative CarePerioperative medicinelcsh:RD78.3-87.303 medical and health sciences0302 clinical medicineOxygen therapyAnesthesiologyPatients' RoomsIntubation IntratrachealmedicineHumansIntubationContinuous positive airway pressureAdministration IntranasalHigh flow nasal therapyNosePerioperative medicinebusiness.industryOxygen Inhalation TherapyHumidity030208 emergency & critical care medicineOxygenationAnesthesiology and Pain Medicinemedicine.anatomical_structure030228 respiratory systemlcsh:AnesthesiologyAnesthesiaNasal CavitybusinessNoninvasive ventilationBMC Anesthesiology
researchProduct

Robotic-assisted right colectomy. Official expert recommendations delivered under the aegis of the French Association of Surgery (AFC)

2022

: Twenty-seven experts under the aegis of the French Association of Surgery (AFC) offer this reference system with formalized recommendations concerning the performance of right colectomy by robotic approach (RRC). For RRC, experts suggest patient installation in the so-called "classic" or "suprapubic" setup. For patients undergoing right colectomy for a benign pathology or cancer, RRC provides no significant benefit in terms of intra-operative blood loss, intra-operative complications or conversion rate to laparotomy compared to laparoscopy. At the same time, RRC is associated with significantly longer operating times. Data from the literature are insufficient to define whether the robot f…

Operative TimeRight colectomyGeneral MedicineRecommendationsLength of StayTreatment OutcomeRobotic Surgical ProceduresMinimally invasive surgeryColonic NeoplasmsOncological colonic resectionQuality of LifeSurgery by robotic approachHumansLaparoscopyColectomyRetrospective StudiesJournal of Visceral Surgery
researchProduct